Theravance Biopharma, Mylan report "positive" data from YUPELRI studies
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Asian shares turn higher after positive China data
Asian shares reversed early losses on Friday as an unexpected bounce in Chinese manufacturing activity offset some negativity cast by a Bloomberg news report that raised doubts over whether the United States and China can reach a long-term trade deal......»»
Theravance Biopharma announces "positive" results from Phase 1 trial of TD-8236
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
TH Data Capital "positive" on Alibaba ahead of Q1 earnings report
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Theravance Biopharma presents new data from Phase 2 study of ampreloxetine
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bond Report: Yields dip on 10-year U.S. Treasurys to third-lowest level of the year
10-year yields mostly unchanged by positive economic data.....»»
Piper reiterates $55 price target on Theravance after "positive" data
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Theravance Biopharma reports new data from Phase 2 clinical study of TD-9855
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Concert Pharma"s CTP-692 Positive for Schizophrenia in Phase I
Concert Pharma (CNCE) reports favorable data from the two early-stage studies on its pipeline candidate, CTP-692, currently under evaluation as an adjunctive treatment for schizophre.....»»
Myovant Sciences Provides Corporate Updates and Reports Financial Results for Fourth Fiscal Quarter and Full Fiscal Year Ended March 31, 2019
-Announced positive Phase 3 results from LIBERTY 1 study evaluating relugolix combination therapy in women with uterine fibroids- -Data from four additional Phase 3 clinical studies ex.....»»
Theravance Biopharma reports data from Phase 1b study of JAK inhibitor TD-1473
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AzurRx BioPharma reports "positive" secondary endpoint data in MS1819-SD study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Theravance, Mylan study highlights possible role of Yupelri in COPD treatment
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Stocks turn positive after strong consumer sentiment report
Stocks recovered earlier losses Friday after the release of stronger sentiment data quelled trade fears......»»
Stocks turn positive after strong consumer sentiment report
Stocks recovered earlier losses Friday after the release of stronger sentiment data quelled trade fears......»»
US stock futures lower after Trump tweet, weak China data
The Chinese report reversed positive investor sentiment that stemmed from President Trump saying late Tuesday on Twitter that a U.S.-China trade deal could be possible soon......»»
Bond Report: Treasury yields edge higher after positive China data
Treasury yields inch higher Wednesday as a round of upbeat Chinese economic data, lifts appetite for risk assets and triggers selling in government bonds across U.S. and Europe......»»
Seattle Genetics, Astellas Report Positive Cancer Study Data
Seattle Genetics (SGEN) and partner Astellas present positive top-line data from the first cohort of a phase II study on enfortumab vedotin for treating patients with advan.....»»
Moleculin Biotech reports "positive" interim data from studies of Annamycin
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AzurRx BioPharma announces "positive" preclincal data for AZX1103
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»